Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Niramas Utama Tbk. (JELI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Niramas Utama Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Niramas Utama Tbk. trades at Rp635 (market cap 848.22B, 10.75M 24h volume). The key difference: Niramas Utama Tbk. is far larger — about 2.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Niramas Utama Tbk. is more actively traded (10.75M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | JELI | |
|---|---|---|
Market Cap | 316.25B | 848.22B |
Volume | 41.7K | 10.75M |
Lot | 417 | 107.48K |
Turnover | 9.66M | 6.9B |
Average Price | 231.65 | 642.24 |
Value | 9.66M | 6.9B |
Indicative Equilibrium Price | 230 | 635 |
Indicative Equilibrium Volume | 2.4K | 6.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Niramas Utama Tbk.
PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →
